Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of 8 mg galantamine hydrobromide prolonged-release capsules under fasting and fed conditions
TCTR20190227001Phase 4Completed
- Sponsor
- Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University
- Start
- Aug 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of galantamine, sponsored by Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University. Started Aug 2014; status: completed.
02
Drugs
galantamine
Beyond the preview
Go deeper on TCTR20190227001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190227001.